Number and percentage of individuals by demographic variables, stratified by physician-attestation status
| . | Individuals with a physician-attested SCD diagnosis, n (%) . |
|---|---|
| Total population | 10 412 |
| Age on 31 December 2024, y | |
| <18 | 4 393 (42) |
| 18 to <26 | 2 027 (19) |
| ≥26 | 3 992 (38) |
| Sex | |
| Female | 5 418 (52) |
| Male | 4 994 (48) |
| Race | |
| Data provided | |
| Black/African American | 9 419 (97) |
| White | 211 (2) |
| Asian | 42 (<1) |
| American Indian/Alaskan Native | 9 (<1) |
| Native Hawaiian or Pacific Islander | 2 (<1) |
| Missing | 729 (7) |
| Ethnicity | |
| Data provided | |
| Hispanic | 953 (9) |
| Non-Hispanic | 9 181 (91) |
| Missing | 278 (7) |
| Sickle cell type | |
| HbSS | 6 782 (65) |
| HbS/β0 | 251 (2) |
| HbSC | 2 602 (25) |
| HbS β+ | 669 (6) |
| Other type | 108 (1) |
| Type of sites | |
| Pediatric only | 5 285 (51) |
| Adult only | 2 703 (26) |
| Life span | 2 424 (23) |
| . | Individuals with a physician-attested SCD diagnosis, n (%) . |
|---|---|
| Total population | 10 412 |
| Age on 31 December 2024, y | |
| <18 | 4 393 (42) |
| 18 to <26 | 2 027 (19) |
| ≥26 | 3 992 (38) |
| Sex | |
| Female | 5 418 (52) |
| Male | 4 994 (48) |
| Race | |
| Data provided | |
| Black/African American | 9 419 (97) |
| White | 211 (2) |
| Asian | 42 (<1) |
| American Indian/Alaskan Native | 9 (<1) |
| Native Hawaiian or Pacific Islander | 2 (<1) |
| Missing | 729 (7) |
| Ethnicity | |
| Data provided | |
| Hispanic | 953 (9) |
| Non-Hispanic | 9 181 (91) |
| Missing | 278 (7) |
| Sickle cell type | |
| HbSS | 6 782 (65) |
| HbS/β0 | 251 (2) |
| HbSC | 2 602 (25) |
| HbS β+ | 669 (6) |
| Other type | 108 (1) |
| Type of sites | |
| Pediatric only | 5 285 (51) |
| Adult only | 2 703 (26) |
| Life span | 2 424 (23) |